These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3248993)

  • 1. Splenomegaly and hepatomegaly at onset of blastic crisis in chronic myeloid leukaemia have prognostic importance.
    Parikh PM; Charak BS; Banavali SD; Koppikar SB; Giri NK; Kumar A; Saikia TK; Gopal R; Mazumdar AT; Advani SH
    J Assoc Physicians India; 1988 Nov; 36(11):653-5. PubMed ID: 3248993
    [No Abstract]   [Full Text] [Related]  

  • 2. Long duration priapism in blast crisis of chronic myeloid leukemia.
    Dogra PN; Kumar P; Goel R; Dash SC
    J Assoc Physicians India; 2004 Feb; 52():170. PubMed ID: 15656063
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia.
    Kashimura M; Ohyashiki K
    Leuk Res; 2010 Aug; 34(8):e213-4. PubMed ID: 20299093
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic granulocytic leukemia in blastic crisis. Prognostic factors.
    Sales V; Rojo J; Collazo J; Lagunas E; Aguilar E; Albisua L
    In Vivo; 1991; 5(3):281-5. PubMed ID: 1893082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of Ph-negative normal clone and long-term survival by combined treatment with G-CSF plus middle dose cytosine arabinoside for patients with chronic myeloid leukemia in blastic transformation].
    Katagiri T; Miyazawa K; Uchida Y; Hayashi S; Iwama H; Shyohji N; Kawakubo K; Shimamoto T; Inatomi Y; Kuriyama Y; Yaguchi M; Nehashi Y; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1998 Dec; 39(12):1149-56. PubMed ID: 10028846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic granulocytic leukemia in blastic crisis.
    Canellos GP
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():131-2. PubMed ID: 2565744
    [No Abstract]   [Full Text] [Related]  

  • 7. The plicamycin and hydroxyurea combination chemotherapy for chronic granulocytic leukemia in myeloid transformation.
    Antimi M; Masi M; Delannoy A; Ferrant A; Doyen C; Debusscher L; Delwiche F; Stryckmans P; Papa G
    Haematologica; 1990; 75(5):443-6. PubMed ID: 2151448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival in chronic myeloid leukemia.
    Malhotra H
    J Assoc Physicians India; 1994 Apr; 42(4):345. PubMed ID: 7619118
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy and imatinib-induced molecular remission in lymphoid blast crisis after 20 years of "untreated" chronic myeloid leukemia.
    Koca E; Sevimli F; Cetiner D; Haznedaroglu IC; Sayinalp N; Büyükasik Y; Goker H; Ozcebe O
    Am J Hematol; 2007 Apr; 82(4):333. PubMed ID: 17094091
    [No Abstract]   [Full Text] [Related]  

  • 10. Idarubicin in acute leukemia: results of studies at Memorial Sloan-Kettering Cancer Center.
    Berman E; Raymond V; Gee T; Kempin SJ; Gulati S; Andreeff M; Kolitz J; Gabrilove J; Heller G; Young CW
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):30-4. PubMed ID: 2928808
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic granulocytic leukaemia. A study of 160 cases.
    Kumar L; Sagar TG; Maitreyan V; Majhi U; Shanta V
    J Assoc Physicians India; 1990 Dec; 38(12):899-902. PubMed ID: 2096123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib.
    Fang B; Song Y; Han Z; Wei X; Lin Q; Zhu X; Yang R; Sun J; Tian G; Liu X; Cao G; Shi Y; Nie N; Li D; Zhao RC
    Leuk Res; 2007 Oct; 31(10):1441-4. PubMed ID: 17383001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of cyclosporin A and etoposide. Clinical and in vitro assessment in blast phase of chronic myeloid leukaemia.
    Maia RC; Noronha H; Vasconcelos FC; Rumjanek VM
    Clin Lab Haematol; 1997 Sep; 19(3):215-7. PubMed ID: 9352149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myelocytic leukemia in children].
    Poliakov VE
    Feldsher Akush; 1991 Nov; 56(11):23-9. PubMed ID: 1807975
    [No Abstract]   [Full Text] [Related]  

  • 15. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F
    Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.
    Olsson-Strömberg U; Aleskog A; Björnberg A; Höglund M; Simonsson B; Bengtsson M; Barbany G; Larsson R; Lindhagen E
    Anticancer Drugs; 2006 Jul; 17(6):631-9. PubMed ID: 16917208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
    Fruehauf S; Topaly J; Buss EC; Fischer T; Ottmann OG; Emmerich B; Müller MC; Schuld P; Balleisen L; Hehlmann R; Ho AD; Hochhaus A
    Cancer; 2007 Apr; 109(8):1543-9. PubMed ID: 17340589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemia.
    Breccia M; Serrao A; Salaroli A; Loglisci G; Zacheo I; Alimena G
    Br J Haematol; 2012 Dec; 159(5):612-3. PubMed ID: 23043319
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
    Derderian PM; Kantarjian HM; Talpaz M; O'Brien S; Cork A; Estey E; Pierce S; Keating M
    Am J Med; 1993 Jan; 94(1):69-74. PubMed ID: 8420302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disappearance of Ph1 chromosome with intensive chemotherapy and detection of minimal residual disease by polymerase chain reaction in a patient with blast crisis of chronic myelogenous leukemia.
    Honda H; Miyagawa K; Endo M; Takaku F; Yazaki Y; Hirai H
    Int J Hematol; 1993 Jun; 57(3):221-7. PubMed ID: 8364186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.